Bal Pharma Limited — Others, 07-04-2025: Structural Digital Database

Bal Pharma Limited has announced a board meeting to discuss compliance with the Structured Digital Database (SDD) requirements, confirming that it has established and maintained a non-tamperable system for managing Unpublished Price Sensitive Information (UPSI) for up to eight years. The company captured one required event during the quarter ended March 31, 2025, and observed no noncompliance issues. This robust compliance framework may enhance investor confidence, indicating a strong governance structure and potential for stable operations, fostering a positive outlook for shareholder interests.